Daily News Analysis

GLP-1 Drugs

stylish_lining

The World Health Organization (WHO) has recently issued global guidelines on the use of popular GLP-1 drugs for weight loss.

About GLP-1 Drugs

Glucagon-like peptide-1 (GLP-1) receptor agonists are synthetic drugs used primarily for the treatment of obesity in adults.

  • These drugs are mainly injectables, although oral versions are under development.

  • Leading examples include Semaglutide and Tirzepatide (developed by Eli Lilly).

  • Both drugs have been introduced in India and are transforming obesity and diabetes treatment.

How Do GLP-1 Drugs Work?

GLP-1 drugs function through multiple mechanisms:

  1. Increase insulin secretion when blood glucose levels are high.

  2. Inhibit glucagon release, reducing glucose output by the liver.

  3. Slow gastric emptying, preventing sudden spikes in blood sugar.

  4. Suppress appetite, making individuals feel full sooner.


 

Key Facts About Glucagon-like Peptide-1

  • GLP-1 is both an incretin hormone and a neurotransmitter.

  • It is a naturally occurring gut hormone, released after food intake.

  • GLP-1 is secreted from the small intestine and the hindbrain after a meal.

  • It travels to the pancreas, where it helps regulate blood sugar by increasing insulin and decreasing glucagon.

  • Its natural effect lasts only a few minutes, giving immediate but short-term regulation of blood sugar after meals.

  • GLP-1 also has beneficial effects on organs like the kidney, liver, and cardiovascular system.


 

World AIDS Day 2025

The Ministry of Health and Family Welfare observed World AIDS Day 2025 under the theme: “Overcoming disruption, transforming the AIDS response.” The event highlighted India’s p
Share It

Kerala Landslides

The Union Government recently sanctioned only ₹260 crore in disaster relief to Kerala following the Wayanad landslides of July 2024, despite the State’s estimated losses of ₹2,200 crore.
Share It

National Judicial Policy

The Chief Justice of India, Justice Surya Kant, has called for the formulation of a National Judicial Policy to reduce divergence in judicial functioning across courts. He also stated that the Sup
Share It

India’s Bioeconomy

India aims to achieve a $1.2 trillion bioeconomy by 2047, which will require capital-market innovation, regulatory modernization, and a strategic blend of technological and scientific innovation.
Share It

Vanashakti Case

The Vanashakti case was filed by the environmental NGO Vanashakti, challenging the legality of retrospective (post-facto) environmental clearances (ECs) granted to industrial and construction proj
Share It

Exercise EKUVERIN

The 14th edition of Exercise EKUVERIN is scheduled to take place in Thiruvananthapuram, Kerala. About Exercise EKUVERIN The word “Ekuverin” means ‘Friends’ in the Dhi
Share It

Judicial Backlog in India

India’s judicial system is facing a serious backlog of cases, with over 4.8 crore cases pending across various courts. Many cases have been pending for decades, highlighting the urgent need
Share It

India’s Fiscal Federalism

India needs to ensure equitable fiscal federalism by strengthening states’ financial autonomy and restoring balance in tax devolution and grants. A healthy fiscal federal structure is essent
Share It

United Nations Secretary-General

The United Nations has officially launched the selection process for the next Secretary-General (SG), who will assume office in January 2027, after Antonio Guterres completes his second term on 31
Share It

Assam Prohibition of Polygamy Bill, 2025

The Chief Minister of Assam introduced the Assam Prohibition of Polygamy Bill, 2025 in the Assam Legislative Assembly with the objective of criminalizing polygamy across the state. The Bill seeks
Share It

Newsletter Subscription


ACQ IAS
ACQ IAS